Skip to the page

Data / Form D filings / Corami Biotech Inc.

Corami Biotech Inc.: Form D filings

Corami Biotech Inc., a biotechnology company in Memphis, TN, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on April 22, 2026, reports $230,000 sold of a $1 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
5395 N ANGELA ROAD, Memphis, TN, 38120
Phone
(901) 826-9132
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2042505

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 22, 2026New notice$1,000,000$230,000$770,0003Feb 4, 2026sec.gov
Jan 17, 2025New notice$100,000$0$100,0000Yet to occursec.gov
Oct 28, 2024New notice$110,000$0$110,0002Oct 24, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Esra RoanExecutive Officer, Director
Rifat PamukcuDirector
Brian WalshDirector
Nathaniel SmithDirector

Other biotechnology companies in Tennessee that filed recently

Every Form D from the week of Apr 20, 2026 · All recent filings in Tennessee · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Corami Biotech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.